Losartan Potassium
Product Images NDC 66116-415

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 66116-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B75d00af-figure-01 (69605072 F130 4054 95b0 Ff3c34554fb9 01)

FDA Label Image

B75d00af-figure-02 (69605072 F130 4054 95b0 Ff3c34554fb9 02)

The text appears to be a comparison of two medications, Atenolol and Losartan Potassium, in terms of their effectiveness in reducing the primary endpoint risk in patients. It presents a graph showing the percentage of patients with the primary endpoint over a period of 66 months, with an adjusted risk reduction of 1% and a p-value of 0.021.*

FDA Label Image

B75d00af-figure-03 (69605072 F130 4054 95b0 Ff3c34554fb9 03)

The text appears to be a chart or graph with medication names "Atenolol" and "Losartan Potassium" listed. The graph seems to be monitoring the occurrence of fatal/non-fatal stroke in patients over time, with percentages listed along the y-axis and months listed along the x-axis. Without more information or a clear image of the chart, it is difficult to provide a more detailed description.*

FDA Label Image

B75d00af-figure-04 (69605072 F130 4054 95b0 Ff3c34554fb9 04)

This appears to be a chart or table related to stroke statistics, including age and ethnicity demographics, as well as information on stroke type (fatal/non-fatal). However, the formatting and text do not provide a clear or comprehensive understanding of the data.*

FDA Label Image

B75d00af-figure-05 (69605072 F130 4054 95b0 Ff3c34554fb9 05)

FDA Label Image

B75d00af-figure-06 (69605072 F130 4054 95b0 Ff3c34554fb9 06)

FDA Label Image

B75d00af-figure-07 (69605072 F130 4054 95b0 Ff3c34554fb9 07)

FDA Label Image

Losartan Potassium Tablets 50mg (69605072 F130 4054 95b0 Ff3c34554fb9 08)

Dosage information for MED/NTX® is available in the package insert. The text also contains instructions to take Losartan tablets, emphasizing not to let the medication run out for several days, and to keep the tablets out of children's reach. The text also includes a sample label for USP 50mg Tablets, along with a contact number to call. It is an advertisement from the company medvantx.com based in San Diego, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.